TECNIS Toric II (ZCU)AcrySof IQ ToricAT TORBI 709M
TECNIS Toric II (ZCU): Using TECNIS Toric II (ZCU) intraocular lens during standard phacoemulsification cataract surgery.
AcrySof IQ Toric: Using AcrySof IQ Toric intraocular lens during standard phacoemulsification cataract surgery.
AT TORBI 709M: Using the AT TORBI 709M intraocular lens during standard phacoemulsification cataract surgery.
Study summary
This prospective comparative cohort study evaluates and compares postoperative rotational stability and time-course dynamics of three commercially available toric intraocular lenses (TECNIS Toric II \[ZCU\], AcrySof IQ Toric, and AT TORBI 709M) after phacoemulsification cataract surgery. Rotation is quantified by registering postoperative retroillumination photographs to the end-of-surgery baseline using iris/scleral landmarks, with follow-up at postoperative day 1, day 3, week 1, week 2, month 1, and month 3. Associations between rotational outcomes and ocular biometric parameters are analyzed using linear mixed-effects models to inform individualized IOL selection and perioperative management.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Adults aged 18 years or older with age-related cataract scheduled for phacoemulsification cataract surgery.
* Presence of regular corneal astigmatism requiring toric intraocular lens implantation.
* Eligible for implantation of one of the three study toric intraocular lenses based on preoperative evaluation.
* Ability to understand the study procedures and provide written informed consent.
Exclusion Criteria:
* History of prior ocular surgery in the study eye.
* History of ocular trauma in the study eye.
* Irregular corneal astigmatism or corneal pathology affecting reliable biometric measurement.
* Intraoperative complications, including anterior capsular tear or posterior capsular rupture.
* Inadequate pupillary dilation during surgery or postoperative examinations.
* Evidence of zonular weakness, zonular dialysis, or lens subluxation.
* Active ocular infection or inflammation.
* Any other ocular or systemic condition judged by the investigator to potentially affect intraocular lens stability or study outcomes.
Primary outcome measure(s)
Absolute rotational misalignment of toric intraocular lens (IOL) measured in degrees — Postoperative day 1, day 3, week 1, week 2, month 1, and month 3. Absolute rotation of the implanted toric intraocular lens (IOL) relative to the intended axis, measured in degrees. Rotation will be quantified by registering postoperative retroillumination images to the end-of-surgery baseline frame using iris or scleral landmarks. The absolute rotation angle will be calculated for each follow-up visit.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.